| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| T1015 |
Clinic visit/encounter, all-inclusive |
39,139 |
33,730 |
$6.21M |
| 87428 |
|
2,304 |
1,628 |
$97K |
| G0467 |
Federally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit |
3,659 |
3,074 |
$72K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,496 |
1,305 |
$52K |
| 99393 |
Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) |
1,244 |
1,016 |
$48K |
| 99394 |
Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) |
1,053 |
754 |
$35K |
| 99392 |
Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) |
791 |
639 |
$32K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
5,168 |
4,231 |
$18K |
| 90686 |
|
448 |
407 |
$5K |
| 0001A |
|
74 |
72 |
$4K |
| 0002A |
|
49 |
49 |
$4K |
| J1050 |
Injection, medroxyprogesterone acetate, 1 mg |
121 |
77 |
$4K |
| 90734 |
|
397 |
356 |
$4K |
| 90670 |
|
373 |
365 |
$4K |
| 90651 |
|
391 |
345 |
$4K |
| 90633 |
|
312 |
296 |
$3K |
| G2025 |
Payment for a telehealth distant site service furnished by a rural health clinic (rhc) or federally qualified health center (fqhc) only |
79 |
67 |
$3K |
| 90710 |
|
252 |
238 |
$3K |
| 99391 |
Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) |
41 |
41 |
$2K |
| 81025 |
|
715 |
503 |
$2K |
| 90715 |
|
256 |
218 |
$2K |
| 90647 |
|
227 |
222 |
$2K |
| 90723 |
|
190 |
186 |
$2K |
| 90656 |
|
142 |
134 |
$831.72 |
| 90661 |
|
47 |
44 |
$567.48 |
| 90696 |
|
50 |
50 |
$497.04 |
| 36415 |
Collection of venous blood by venipuncture |
978 |
908 |
$480.00 |
| 90655 |
|
48 |
42 |
$363.28 |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
963 |
846 |
$329.34 |
| 99395 |
Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years |
29 |
25 |
$305.05 |
| 90697 |
|
18 |
13 |
$200.85 |
| 90649 |
|
41 |
20 |
$197.10 |
| 90677 |
|
15 |
13 |
$170.82 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
162 |
139 |
$154.40 |
| 90658 |
|
13 |
13 |
$114.72 |
| 87430 |
|
380 |
331 |
$26.22 |
| Q3014 |
Telehealth originating site facility fee |
12 |
12 |
$25.40 |
| J1030 |
Injection, methylprednisolone acetate, 40 mg |
184 |
171 |
$8.57 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
89 |
81 |
$8.16 |
| 81002 |
|
67 |
63 |
$3.66 |
| 81003 |
|
124 |
119 |
$3.60 |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
263 |
242 |
$1.72 |
| 90619 |
|
34 |
31 |
$0.00 |
| 1036F |
|
28 |
27 |
$0.00 |
| 3074F |
|
86 |
83 |
$0.00 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
16 |
14 |
$0.00 |
| 3351F |
|
14 |
14 |
$0.00 |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
124 |
121 |
$0.00 |
| T1014 |
Telehealth transmission, per minute, professional services bill separately |
12 |
12 |
$0.00 |
| 1000F |
|
17 |
16 |
$0.00 |
| 3078F |
|
55 |
53 |
$0.00 |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
499 |
452 |
$0.00 |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
164 |
145 |
$0.00 |
| 1159F |
|
517 |
470 |
$0.00 |
| 1160F |
|
49 |
49 |
$0.00 |